Skip to main content
. 2017 Jun 23;12(6):e0179614. doi: 10.1371/journal.pone.0179614

Fig 5. Scheme representing the suppression of collagen production in HDFs after Lipo-PGE1 treatment.

Fig 5

Lipo-PGE1 strongly inhibits collagen synthesis in HDFs. Furthermore, an ERK- and Ets-1-dependent pathway is involved in Lipo-PGE1-inhibited collagen production. Lipo-PGE1 can be modulated to down-regulate collagen synthesis in human HDFs and may provide a therapeutic approach to inhibit fibrosis and its roles in the pathogenesis of skin disorders.